>
pdufa.bio

Tirzepatide

Updated ยทnext FDA decision on the calendar

Tirzepatide is a ELI LILLY & Co program. Its next catalyst is a Readout in Oct 2027. Every date links its source.

LLY catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: ELI LILLY & Co (LLY). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Oct 2027LLY

Questions

When is Tirzepatide's next FDA decision or readout?

The next tracked catalyst for Tirzepatide is a Readout in Oct 2027.

What happened at Tirzepatide's most recent FDA decision?

No FDA decision for Tirzepatide is in our archive yet.

Who makes Tirzepatide?

ELI LILLY & Co (LLY).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.